Highlights
- Universal Biosensors (ASX:UBI) remains suspended from Quotation following financial challenges involving its operating subsidiary.
- The suspension relates to administration and financial condition concerns rather than unpaid listing fees.
- The company’s operating Subsidiary entered voluntary administration and later liquidation.
- Investors are monitoring Liquidation progress, potential asset outcomes and the company’s ASX status.
Universal Biosensors (ASX:UBI), a Melbourne-based electrochemical diagnostics company, remains suspended from trading on the Australian Securities Exchange as at 24 August 2026. The company’s suspension relates to the financial position…